About this trial
Premenstrual dysphoric disorder (PMDD) is a sex-specific depressive disorder where depressive symptom severity drastically changes in relation to menstrual cycle phase. It is characterized by late luteal phase symptoms of affective lability, irritability, depressed mood, and anxiety. A lot remains unclear and further studies are needed in order to improve the understanding of PMDD and to differentiate it from major depressive disorder (MDD). To date, and in contrast to MDD, the neural correlates of PMDD have been sparsely and poorly investigated. The aim of this study is therefore to investigate the neural correlates of PMDD as compared to MDD and to relate them to stress reactivity. Therefore, three groups of naturally cycling women will be investigated and compared, namely (1) women with MDD, (2) women with PMDD, and (3) healthy control women.
Stress and HPA axis activity are assumed to play a crucial role in the development of many mental disorders, including MDD. How stress reactivity and HPA axis activity are connected to PMDD still needs to be investigated. Furthermore, the HPA axis can affect or suppress the activity of the hypothalamic-pituitary-gonadal (HPG) axis, which is involved mainly in the reproductive, but also the immune system, making it an important candidate for the investigation of sex-specific differences in stress reactivity.
There are sex-specific differences in stress reactivity, but also in the prevalence of stress-related diseases. Women are twice as likely to suffer from depression than men and the first onset of MDD usually peaks during the reproductive years. As to why these differences exist, a recent theory suggests that ovarian hormone fluctuations function as modulators of women's susceptibility to stress and that altered reactivity to stressors during different cycle phases plays a role in the etiology of depressive disorders. This hypothesis extends the Social Signal Transduction Theory of Depression which first and foremost relates depression to inflammation. They postulate a critical role of cytokines for understanding the pathogenesis of depression. Therefore, ovarian hormone fluctuations, but also inflammation in regard to MDD and PMDD and stress reactivity will be investigated in this study.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Women,
age between 18 and 40 years (no menopausal women),
regular menstrual cycles (25-31 days),
normal body mass index (18-35 kg/m2),
Disqualifiers
any neurological or mental disease (only for healthy participants)
hormonal, metabolic or chronical diseases
pregnancy
women who gave birth or were breastfeeding within the last year
Trial population
Participants will be recruited by newspaper/social media advertisements, e-mails ("Rundmail") and posting notices ("Aushänge") at different places at the University Hospital Tübingen as well as the University of Tübingen and in social networks.
Trial design
Cohort
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
neural stress reactivity / activation of the CCN (cognitive control network) during stress-related tasks
activity in stress-circuits of the brain, especially DLPFC activity
stress-related cortisol reactivity
cortisol level change in saliva between before and after the MIST
TNF-alpha in response to stress-related task
TNF-alpha in blood before / after the MIST
CRP in response to stress-related task
CRP in blood before / after the MIST
Secondary outcomes
different levels of inflammation in Major Depressive Disorder, Premenstrual Dysphoric Disorder and Healthy Controls
ANOVA for different levels of CRP in different groups (PMDD, MDD, control)
different levels of inflammation in Major Depressive Disorder, Premenstrual Dysphoric Disorder and Healthy Controls
ANOVA for different levels of IL-6 in different groups (PMDD, MDD, control)
different levels of inflammation in Major Depressive Disorder, Premenstrual Dysphoric Disorder and Healthy Controls
ANOVA for different levels of TNF-alpha in different groups (PMDD, MDD, control)
changes in stress-reactivity induced by varying levels of sex hormones
ANOVA for cortisol reactivity between different cycle phases (luteal phase, follicular phase)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.